Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia | Zendy

Dirk Bassler | Zendy; Richard Plavka | Zendy; Eric S. Shinwell | Zendy; Mikko Hallman | Zendy; PierreHenri Jarreau | Zendy; Virgilio Carnielli | Zendy; Johannes N. van den Anker | Zendy; Christoph Meisner | Zendy; Corinna Engel | Zendy; Matthias Schwab | Zendy; Henry L. Halliday | Zendy; Christian F. Poets | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia

Author(s) -

Dirk Bassler,

Richard Plavka,

Eric S. Shinwell,

Mikko Hallman,

PierreHenri Jarreau,

Virgilio Carnielli,

Johannes N. van den Anker,

Christoph Meisner,

Corinna Engel,

Matthias Schwab,

Henry L. Halliday,

Christian F. Poets

Publication year - 2015

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1501917

Subject(s) - bronchopulmonary dysplasia , medicine , budesonide , incidence (geometry) , pediatrics , intensive care medicine , inhalation , anesthesia , pregnancy , gestational age , genetics , biology , physics , optics

Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. The effects of inhaled glucocorticoids on outcomes in these infants are unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research